HCV in children and pregnancy
Infections of the
In
HCV infection is frequently found in children who have previously been presumed to have non-A, non-B
Diagnosis
Guidelines for the investigation of babies born to hepatitis C positive mothers have been published.[8]
- In children born to hepatitis C virus alanine aminotransferase and hepatitis C virus antibodies should be investigated at 18-24 months of life. If both the alanine aminotransferase value is normal and hepatitis C virus antibody is not found, follow up should be interrupted.[citation needed]
- In children born to hepatitis C virus RNA positive mothers, alanine aminotransferase and hepatitis C virus RNA should be investigated at 3 months of age. Of these[citation needed]
- (1) hepatitis C virus RNA positive children should be considered infected if viremia is confirmed by a second assay performed by the 12th month of age
- (2) hepatitis C virus RNA negative children with abnormal alanine aminotransferase should be tested again for viremia at 6-12 months and for antibodies to the hepatitis C virus at 18 months
- (3) hepatitis C virus RNA negative children with normal alanine aminotransferase should be tested for antibodies to the hepatitis C virus and have their alanine aminotransferase reestimated at 18-24 months. They should be considered non infected if both the alanine aminotransferase is normal and the antibody levels to the hepatitis C virus are undetectable.
- The presence of anti hepatitis C virus antibody beyond the 18th month of age in a never viremic child with normal alanine aminotransferase is likely consistent with past hepatitis C virus infection.[citation needed]
Treatment
Treatment of children has been with interferon and ribavirin.[9] The response to treatment is similar to that in adults.[10] It shows a similar dependence on the genotype. Recurrence after transplant is universal and the outcomes after transplant are usually poor.[11]
In children treatment should be initiated within 12 weeks of the detection of the viral RNA if viral clearance has not occurred within this time.[12] Given the difficulties with establishing a diagnosis of hepatitis C infection in infancy, this recommendation does not apply to infants.[citation needed]
Both pegylated interferon and ribavirin are unsuitable for use in pregnancy and infancy: newer methods of treatment are urgently required.[citation needed]